Word

Status

Registered

Status Code

700

Status Date

Tuesday, August 23, 2022

Serial Number

79316849

Registration Number

6823172

Registration Date

Tuesday, August 23, 2022

Mark Type

2000

Filing Date

Friday, April 16, 2021

Published for Opposition

Tuesday, June 7, 2022

Trademark Owner History

Lunac Therapeutics Limited - Original Registrant

Classifications

40 Treatment of materials, namely manipulation of oral small molecules, for use as anticoagulants; custom manufacture of chemicals, medicines, pharmaceuticals and anticoagulants; custom manufacture of therapeutic products and medical diagnostic products; consultancy, advisory and information in connection with all of the aforementioned services

5 Medical and veterinary preparations, namely pharmaceutical preparations for the treatment of blood disorders, conditions of the immune system, cardiological disorders, hormonal conditions, cancer, obstetrical conditions and complications, gynecological conditions, infectious diseases, neonatal illnesses, kidney diseases, neurological conditions, orthopedic conditions, respiratory illnesses, conditions of the urinary tract systems and male reproductive organs, antibiotics for patients undergoing surgical procedures, bacteriological preparations for patients in intensive care, autoimmune diseases and hereditary diseases; medical diagnostic preparations, chemicals, agents for detecting thrombotic conditions, reagents for detecting thrombotic conditions; anticoagulants; anticoagulants for the treatment of medical conditions; anticoagulants for the treatment of thrombosis and blood clots; anticoagulants for use in the discovery, preclinical and clinical development of therapeutic products and medical diagnostic products; medicines and pharmaceuticals, namely anticoagulants for use in the discovery, preclinical and clinical development of therapeutic products and medical diagnostic products

42 Scientific and technological services, namely providing scientific research for medical purposes in the field of blood disorders, conditions of the immune system, cardiological disorders, hormonal conditions, cancer, obstetrical conditions and complications, gynecological conditions, infectious diseases, neonatal illnesses, kidney diseases, neurological conditions, orthopedic conditions, respiratory illnesses, conditions of the urinary tract systems and male reproductive organs, patients undergoing surgical procedures, patients in intensive care, autoimmune diseases and hereditary diseases; research and design in relation to science, technology, pharmaceuticals, medicine, blood, thrombosis and/or anticoagulants; preparation of scientific reports on anticoagulants for medical and veterinary purposes; engineering of medicines and/or pharmaceuticals; engineering of anticoagulants; engineering of medicines and/or pharmaceuticals for the treatment of thrombosis and blood clotting; scientific services relating to the discovery, preclinical and clinical development of therapeutic and medical diagnostic products; consultancy, advisory and information in connection with all of the aforementioned services

The mark consists of an outline of a teardrop with a solid upside down teardrop appearing in the middle.

Trademark Events

Dec 28, 2022

Final Decision Transaction Processed By Ib

Dec 2, 2022

Final Disposition Notice Sent To Ib

Dec 2, 2022

Final Disposition Processed

Nov 23, 2022

Final Disposition Notice Created, To Be Sent To Ib

Aug 23, 2022

Notice Of Registration Confirmation Emailed

Aug 23, 2022

Registered-Principal Register

Jun 7, 2022

Official Gazette Publication Confirmation E-Mailed

Jun 7, 2022

Published For Opposition

May 18, 2022

Notification Of Notice Of Publication E-Mailed

May 2, 2022

Approved For Pub - Principal Register

Apr 26, 2022

Teas/Email Correspondence Entered

Apr 25, 2022

Correspondence Received In Law Office

Apr 25, 2022

Teas Request For Reconsideration Received

Apr 5, 2022

Notification Of Final Refusal Emailed

Apr 5, 2022

Final Refusal E-Mailed

Apr 5, 2022

Final Refusal Written

Feb 23, 2022

Teas/Email Correspondence Entered

Feb 22, 2022

Correspondence Received In Law Office

Feb 22, 2022

Teas Response To Office Action Received

Jan 1, 2022

Refusal Processed By Ib

Dec 14, 2021

Non-Final Action Mailed - Refusal Sent To Ib

Dec 14, 2021

Refusal Processed By Mpu

Dec 11, 2021

Non-Final Action (Ib Refusal) Prepared For Review

Dec 10, 2021

Non-Final Action Written

Dec 9, 2021

Assigned To Examiner

Aug 10, 2021

Application Filing Receipt Mailed

Aug 5, 2021

New Application Office Supplied Data Entered In Tram

Jul 29, 2021

Sn Assigned For Sect 66a Appl From Ib